We are live on ! Find out more
AG

Aperio Group Portfolio holdings

AUM $33.8B
1-Year Est. Return 31.46%
This Fund
S&P 500
This Quarter Est. Return
-11.43%
1 Year Est. Return
+31.46%
3 Year Est. Return
+70.41%
5 Year Est. Return
+146.02%
10 Year Est. Return
AUM
$19.8B
AUM Growth
-$2.83B
Cap. Flow
+$212M
Cap. Flow %
1.07%
Top 10 Hldgs %
15.28%
Holding
2,395
New
108
Increased
1,282
Reduced
892
Closed
107

Top Buys

Rank Stock Value
1
LIN icon
Linde
LIN
+$32.7M
2
CI icon
Cigna
CI
+$31.5M
3
LYB icon
LyondellBasell Industries
LYB
+$27.6M
4
VICI icon
VICI Properties
VICI
+$24.4M
5
CVS icon
CVS Health
CVS
+$21.2M

Sector Composition

Rank Sector Weight
1 Technology 17.58%
2 Financials 16.18%
3 Healthcare 14.54%
4 Consumer Discretionary 9.94%
5 Communication Services 8.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TIMB icon
1051
TIM SA
TIMB
$9.16B
$1.73M 0.01%
112,852
-32,917
-23% -$505K
WWD icon
1052
Woodward
WWD
$21.5B
$1.71M 0.01%
23,077
-489
-2% -$37.7K
FIVN icon
1053
FIVE9
FIVN
$2.11B
$1.71M 0.01%
39,172
+1,595
+4% +$64.2K
WPX
1054
DELISTED
WPX Energy, Inc.
WPX
$1.71M 0.01%
150,886
+48,556
+47% +$736K
DNB
1055
DELISTED
Dun & Bradstreet
DNB
$1.71M 0.01%
11,951
-586
-5% -$83.6K
MKSI icon
1056
MKS Inc
MKSI
$20.1B
$1.71M 0.01%
26,385
+3,327
+14% +$241K
ARI
1057
Apollo Commercial Real Estate
ARI
$867M
$1.7M 0.01%
102,228
+14,333
+16% +$265K
NWLI
1058
DELISTED
National Western Life Group, Inc. Class A
NWLI
$1.7M 0.01%
5,660
-749
-12% -$219K
CACI icon
1059
CACI
CACI
$11B
$1.7M 0.01%
11,771
+2,917
+33% +$496K
FLS icon
1060
Flowserve
FLS
$9.71B
$1.7M 0.01%
44,593
-7,957
-15% -$372K
OPLN
1061
Openlane
OPLN
$4.21B
$1.68M 0.01%
93,057
-6,258
-6% -$130K
RNG icon
1062
RingCentral
RNG
$4.66B
$1.68M 0.01%
20,338
+5,312
+35% +$418K
IPGP icon
1063
IPG Photonics
IPGP
$3.61B
$1.67M 0.01%
14,762
+1,763
+14% +$234K
BB icon
1064
BlackBerry
BB
$4.98B
$1.65M 0.01%
231,956
+118,006
+104% +$1.04M
EGL
1065
DELISTED
Engility Holdings, Inc.
EGL
$1.64M 0.01%
57,730
+9,639
+20% +$300K
TARO
1066
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$1.64M 0.01%
19,380
-2,517
-11% -$243K
HTHT icon
1067
Huazhu Hotels Group
HTHT
$13.1B
$1.64M 0.01%
57,204
+8,852
+18% +$255K
MUSA icon
1068
Murphy USA
MUSA
$11.2B
$1.64M 0.01%
21,371
+5,598
+35% +$441K
NHC icon
1069
National Healthcare
NHC
$3.53B
$1.64M 0.01%
20,845
+3,960
+23% +$310K
CSL icon
1070
Carlisle Companies
CSL
$14.6B
$1.63M 0.01%
16,205
-4,938
-23% -$508K
CXW icon
1071
CoreCivic
CXW
$2.96B
$1.62M 0.01%
91,021
+41,443
+84% +$910K
MGEE icon
1072
MGE Energy Inc
MGEE
$3B
$1.62M 0.01%
27,060
+631
+2% +$40.2K
EE
1073
DELISTED
El Paso Electric Company
EE
$1.62M 0.01%
32,382
-1,232
-4% -$69.4K
BSMX
1074
DELISTED
Banco Santander México, S, A., Institución de Banca Múltiple, Grupo Financiero Santander México
BSMX
$1.62M 0.01%
262,892
-61,931
-19% -$416K
DISH
1075
DELISTED
DISH Network Corp.
DISH
$1.62M 0.01%
64,777
-17,692
-21% -$555K

Similar funds

Aperio Group's Q4 2018 Portfolio in Review

As of Q4 2018, Aperio Group held 2,395 positions worth $19.8B, down 12% from $22.7B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Aperio Group's Q4 2018 filing shows 108 new, 1,282 increased, 892 reduced and 107 closed positions. Its largest new stake was Linde: 206,771 shares worth $32.3M. The largest sale was Aetna Inc, an estimated $67.4M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.

  • Aperio Group's largest Q4 2018 buy was Linde: 206,771 shares worth $32.3M.
  • Aperio Group added most to Cigna in Q4 2018, an estimated $31.5M increase.
  • Aperio Group's biggest Q4 2018 reduction was Apple, cutting an estimated $28.3M.
  • Aperio Group fully exited Aetna Inc in Q4 2018, selling an estimated $67.4M.
  • Aperio Group's ten largest holdings make up 15% of its $19.8B portfolio in Q4 2018.
  • Aperio Group opened 108 new positions and closed 107 in Q4 2018.
  • Aperio Group's portfolio value fell 12% quarter-over-quarter to $19.8B.

Based on Aperio Group's 13F filing for Q4 2018, filed 14 Feb 2019.